Applied Nutrition Income Statement

Financials in millions GBP. Fiscal year is August - July.

Millions GBP. Fiscal year is Aug - Jul.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Revenue	107.1	86.2	60.78	35.23	21.81
Revenue Growth (YoY)	24.25%	41.82%	72.54%	61.51%	94.76%
Cost of Revenue	57.8	44.9	33.81	18.65	10.28
Gross Profit	49.3	41.3	26.97	16.58	11.53
Selling, General & Admin	19.5	16.4	9.3	6.8	4.5
Other Operating Expenses	-	-	-	-	-0.03
Operating Expenses	19.5	16.4	9.3	6.8	4.47
Operating Income	29.8	24.9	17.67	9.78	7.07
Interest Expense	-0.1	-0.1	-	-0.02	-0.03
Interest & Investment Income	0.5	0.7	0.07	-	-
EBT Excluding Unusual Items	30.2	25.5	17.74	9.76	7.04
Other Unusual Items	-1.7	-1.2	-	-	-
Pretax Income	28.5	24.3	17.74	9.76	7.04
Income Tax Expense	7.4	5.6	4.11	1.67	1.2
Net Income	21.1	18.7	13.63	8.08	5.84
Net Income to Common	21.1	18.7	13.63	8.08	5.84
Net Income Growth	12.83%	37.15%	68.65%	38.38%	49.60%
Shares Outstanding (Basic)	250	250	5	-	-
Shares Outstanding (Diluted)	250	250	5	-	-
Shares Change (YoY)	-	4900.00%	-	-	-
EPS (Basic)	0.08	0.07	2.73	-	-
EPS (Diluted)	0.08	0.07	2.73	-	-
EPS Growth	12.83%	-97.26%	-	-	-
Free Cash Flow	14.6	5.7	7.35	6.04	2.25
Free Cash Flow Per Share	0.06	0.02	1.47	-	-
Gross Margin	46.03%	47.91%	44.37%	47.06%	52.88%
Operating Margin	27.82%	28.89%	29.08%	27.76%	32.41%
Profit Margin	19.70%	21.69%	22.43%	22.95%	26.78%
Free Cash Flow Margin	13.63%	6.61%	12.08%	17.14%	10.31%
EBITDA	30.6	25.5	18.08	10.04	7.3
EBITDA Margin	28.57%	29.58%	29.75%	28.49%	33.46%
D&A For EBITDA	0.8	0.6	0.41	0.26	0.23
EBIT	29.8	24.9	17.67	9.78	7.07
EBIT Margin	27.82%	28.89%	29.08%	27.76%	32.41%
Effective Tax Rate	25.96%	23.04%	23.15%	17.16%	17.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.